Rentokil Initial plc has significantly expanded its scale and market presence following the acquisition of Terminix Global Holdings in 2022, marking a pivotal shift in its growth trajectory. The company's strategic focus on R&D, exemplified by the Rentokil Terminix North America Innovation Centre, underpins differentiated service offerings and sustainability initiatives, while its well-capitalized financial structure supports ongoing investments. Capital allocation remains disciplined, with a consistent dividend policy and opportunistic share buybacks highlighting management’s confidence. However, operational complexity in regulated global markets and competitive pressures present ongoing risks.